Professor Laura Magee is the Chief Investigator for the WILL trial.
Laura Magee is a general obstetric internist (Internal Medicine and Clinical Pharmacology, Royal College of Canada) and Fellow ad eundem, Royal College of Obstetricians and Gynaecologists, UK. She has recently joined King’s College London, UK as Professor of Women’s Health following consultant posts at St. George’s, University of London, UK (2015-2017), and the Universities of British Columbia (2000-2015) and Toronto (1996-2000), Canada. Laura’s research is focused on pregnancy hypertension, particularly antihypertensive therapy. She is President-of the International Society for the Study of Hypertension in Pregnancy (ISSHP) and Chair, Maternal Medicine Clinical Study Group of the Royal College of Obstetricians and Gynaecologists (RCOG), UK.